XML 40 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (loss)
Accumulated Deficit
Redeemable Convertible Preferred Stock Beginning Balance (in shares) at Dec. 31, 2018 287,216,434        
Redeemable Convertible Preferred Stock Beginning Balance at Dec. 31, 2018 $ 114,842        
Redeemable Convertible Preferred Stock          
Issuance of Series E-1 redeemable convertible preferred stock (in shares) 38,552,483        
Issuance of Series E-1 redeemable convertible preferred stock $ 142,990        
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares) (11,074,661)        
Conversion of redeemable convertible preferred stock to common stock upon initial public offering $ 13,767        
Deemed dividend upon the exchange of Series A and Series C redeemable convertible preferred stock for Series E redeemable convertible preferred stock $ 64,149        
Redeemable Convertible Preferred Stock Ending Balance (in shares) at Dec. 31, 2019 336,843,578        
Redeemable Convertible Preferred Stock Ending Balance at Dec. 31, 2019 $ 335,748        
Balance at the beginning of the period (in shares) at Dec. 31, 2018   121,411,803      
Balance at the beginning of the period at Dec. 31, 2018 (84,907) $ 12 $ 2,870 $ (1) $ (87,788)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)   (11,074,661)      
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (13,767)   (13,767)    
Issuance of common stock upon exercise of vested options (in shares)   7,767,038      
Issuance of common stock upon exercise of vested options 515   515    
Issuance of common stock upon early exercise of unvested options (in shares)   762,440      
Deemed dividend upon the exchange of Series A and Series C redeemable convertible preferred stock for Series E redeemable convertible preferred stock (64,149)   (4,308)   (59,841)
Repurchase of early exercised stock options (in shares)   (436,589)      
Vesting of early exercised stock options 298   298    
Share-based compensation expense 21,757   21,757    
Change in other comprehensive income (loss) 47     47  
Net loss (58,200)       (58,200)
Balance at the end of the period (in shares) at Dec. 31, 2019   118,430,031      
Balance at the end of the period at Dec. 31, 2019 $ (198,406) $ 12 7,365 46 (205,829)
Redeemable Convertible Preferred Stock          
Issuance of Series E-1 redeemable convertible preferred stock (in shares) 20,989,756        
Issuance of Series E-1 redeemable convertible preferred stock $ 166,942        
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares) (5,988,994)        
Conversion of redeemable convertible preferred stock to common stock upon initial public offering $ (809)        
Redeemable Convertible Preferred Stock Ending Balance (in shares) at Dec. 31, 2020 351,844,340        
Redeemable Convertible Preferred Stock Ending Balance at Dec. 31, 2020 $ 501,881        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)   (5,988,994)      
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (809) $ (1) (808)    
Issuance of common stock upon exercise of vested options (in shares)   5,236,999      
Issuance of common stock upon exercise of vested options 2,472   2,472    
Repurchase of early exercised stock options (in shares)   (190,370)      
Issuance of common stock net settlement of restricted stock units (in shares)   847,184      
Vesting of early exercised stock options 742   742    
Vesting of common stock warrants 171   171    
Share-based compensation expense 28,211   28,211    
Change in other comprehensive income (loss) (21)     (21)  
Net loss (47,695)       (47,695)
Balance at the end of the period (in shares) at Dec. 31, 2020   130,312,838      
Balance at the end of the period at Dec. 31, 2020 $ (213,717) $ 13 39,769 25 (253,524)
Redeemable Convertible Preferred Stock          
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares) (351,844,340)        
Conversion of redeemable convertible preferred stock to common stock upon initial public offering $ (501,881)        
Redeemable Convertible Preferred Stock Ending Balance (in shares) at Dec. 31, 2021 0        
Redeemable Convertible Preferred Stock Ending Balance at Dec. 31, 2021 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon Initial public offering, net of issuance costs (in shares)   52,272,727      
Issuance of common stock upon initial public offering, net of issuance costs 1,312,338 $ 7 1,312,331    
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)   (351,844,340)      
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (501,881) $ (34) (501,847)    
Reclassification of redeemable convertible preferred stock warrant liabilities to common stock and additional paid-in capital upon initial public offering 5,438   5,438    
Issuance of common stock upon exercise of vested options (in shares)   4,277,344      
Issuance of common stock upon exercise of vested options 4,969   4,969    
Issuance of common stock under employee stock purchase plan   153,905      
Issuance of common stock under employee stock purchase plan 3,201   3,201    
Repurchase of early exercised stock options (in shares)   (85,870)      
Issuance of common stock net settlement of restricted stock units (in shares)   1,736,212      
Issuance of common stock upon net settlement of restricted stock units (23,552)   (23,552)    
Issuance of common stock upon exercise of common stock warrants (in shares)   872,022      
Issuance of common stock upon exercise of common stock warrants 60        
Vesting of common stock warrants 6,332   6,332    
Share-based compensation expense 142,660   142,660    
Change in other comprehensive income (loss) (2,255)     (2,255)  
Net loss (163,929)       (163,929)
Balance at the end of the period (in shares) at Dec. 31, 2021   541,383,518      
Balance at the end of the period at Dec. 31, 2021 $ 1,573,426 $ 54 $ 1,993,055 $ (2,230) $ (417,453)